T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.28% |
| 2 | Consumer Discretionary | 14.05% |
| 3 | Financials | 13.42% |
| 4 | Industrials | 12.52% |
| 5 | Technology | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STRZA
1301
DELISTED
Starz - Series A
STRZA
| $10.9M | ﹤0.01% |
366,416
+4,266
| +1% | +$131K |
|
|
ADT
1302
DELISTED
ADT Corp
ADT
| $10.8M | ﹤0.01% |
299,073
+3,242
| +1% | +$112K |
|
1303
iShares Russell 2000 Value ETF
IWN
$14.7B
| $10.6M | ﹤0.01% |
104,010
-9,700
| -9% | -$951K |
|
|
COHR
1304
DELISTED
Coherent Inc
COHR
| $10.6M | ﹤0.01% |
173,950
-2,850
| -2% | -$169K |
|
|
POLY
1305
DELISTED
Plantronics, Inc.
POLY
| $10.5M | ﹤0.01% |
198,550
-4,700
| -2% | -$236K |
|
1306
Precigen
PGEN
$2.25B
| $10.5M | ﹤0.01% |
399,071
-1,361
| -0.3% | -$29.8K |
|
|
TEG
1307
DELISTED
INTEGRYS ENERGY GROUP INC COM (USA)
TEG
| $10.4M | ﹤0.01% |
134,004
-900
| -0.7% | -$65.1K |
|
1308
Hooker Furnishings Corp
HOFT
$157M
| $10.4M | ﹤0.01% |
605,750
-465,940
| -43% | -$7.25M |
|
1309
Transocean
RIG
$6.61B
| $10.4M | ﹤0.01% |
566,700
+5,151
| +0.9% | +$129K |
|
1310
HubSpot
HUBS
$11.4B
| $10.4M | ﹤0.01% |
+308,900
| New | +$10.4M |
|
1311
Teradata
TDC
$2.58B
| $10.4M | ﹤0.01% |
237,366
+300
| +0.1% | +$12.8K |
|
|
CPHD
1312
DELISTED
Cepheid Inc
CPHD
| $10.4M | ﹤0.01% |
191,267
-6,850
| -3% | -$346K |
|
|
SLAI
1313
DELISTED
SOLAI Ltd ADS
SLAI
| $10.2M | ﹤0.01% |
+8,409
| New | +$15.1M |
|
|
RVBD
1314
DELISTED
RIVERBED TECHNOLOGY, INC COM
RVBD
| $10.2M | ﹤0.01% |
500,335
-1,000
| -0.2% | -$19.2K |
|
|
ESL
1315
DELISTED
Esterline Technologies
ESL
| $10.2M | ﹤0.01% |
92,990
-1,900
| -2% | -$214K |
|
1316
NETSCOUT
NTCT
$2.88B
| $10.2M | ﹤0.01% |
278,200
-4,200
| -1% | -$158K |
|
|
PPLI
1317
People Inc
PPLI
$3.01B
| $10.1M | ﹤0.01% |
932,284
+428,031
| +85% | +$4.85M |
|
|
INVX
1318
Innovex International
INVX
$2.21B
| $10.1M | ﹤0.01% |
131,800
-3,500
| -3% | -$292K |
|
|
RTI
1319
DELISTED
RTI INTL METALS INC(HLDG CO)
RTI
| $10.1M | ﹤0.01% |
400,302
+227,392
| +132% | +$5.35M |
|
|
RKT
1320
DELISTED
ROCK-TENN COMPANY CL-A
RKT
| $10.1M | ﹤0.01% |
164,948
+4,075
| +3% | +$221K |
|
1321
Accuray
ARAY
$33M
| $10M | ﹤0.01% |
1,325,000
+87,420
| +7% | +$617K |
|
|
QVCGA
1322
DELISTED
QVC Group Inc Series A
QVCGA
| $9.98M | ﹤0.01% |
6,988
-1,274
| -15% | -$1.67M |
|
|
SHPG
1323
DELISTED
Shire pic
SHPG
| $9.96M | ﹤0.01% |
46,877
+44,927
| +2,304% | +$9.53M |
|
1324
Ziff Davis
ZD
$1.89B
| $9.96M | ﹤0.01% |
184,690
+690
| +0.4% | +$33.4K |
|
|
AFSI
1325
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $9.9M | ﹤0.01% |
352,186
+3,000
| +0.9% | +$75.5K |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.